Bill > HB3357

This bill prohibits the sale and distribution of intravenous solution containers and intravenous tubing products that intentionally contain DEHP, which stands for di(2-ethylhexyl) phthalate, a type of chemical known as an ortho-phthalate. Specifically, starting January 1, 2030, intravenous solution containers with intentionally added DEHP will be banned, and beginning January 1, 2035, intravenous tubing with intentionally added DEHP will also be prohibited. The bill also prevents manufacturers from substituting DEHP with other ortho-phthalates in these medical devices and sets a limit for unintentionally added DEHP at one-tenth of one percent by weight. Certain medical items, like blood collection and storage bags, are exempt, and there are provisions for extending the deadline for compliance with the ban on intravenous solution containers under specific circumstances related to regulatory approval or manufacturing challenges, provided certain notification requirements are met.

https://house.mo.gov/Bill.aspx?bill=HB3357&year=2026&code=R